News

UPDATE: JPMorgan Downgrades Y-mAbs Therapeutics to Underweight

ByInvesting.com

Oct 31, 2022
UPDATE: Northland Capital Markets Starts Stem Inc. at Outperform

[ad_1]

UPDATE: JPMorgan Downgrades Y-mAbs Therapeutics to Underweight

[ad_2]

Image and article originally from www.investing.com. Read the original article here.

By Investing.com

Related Post

News

No more ‘special awards’ for JPMorgan CEO Jamie Dimon, board decides

Jan 19, 2023 admin
News

New York state to forgive $672 million of overdue gas, electric bills By Reuters

Jan 19, 2023 Reuters
News

Quiet quitting is real, and its your managers fault, Davos leaders say

Jan 19, 2023 admin

You missed

News

No more ‘special awards’ for JPMorgan CEO Jamie Dimon, board decides

Jan 19, 2023 admin
Stocks

Costco Stock Is Moving Higher After Hours: What’s Going On?

Jan 19, 2023 Adam Eckert
Investing

Stocks making the biggest moves after hours: Netflix, Nordstrom and more

Jan 19, 2023 admin
News

New York state to forgive $672 million of overdue gas, electric bills By Reuters

Jan 19, 2023 Reuters